Back to News
Market Impact: 0.2
Creative Medical Expands Ultrasome Intellectual Property Portfolio
Source: Nasdaq
Patents & Intellectual PropertyHealthcare & BiotechTechnology & Innovation
Creative Medical Technology Holdings filed a new U.S. provisional patent application to broaden intellectual-property protection for its proprietary Ultrasome regenerative-medicine platform. The filing could strengthen CELZ's technology moat and development optionality, but the article provides no clinical, commercial, or financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
CELZ0.55
More News
- Google's Gemini becomes latest AI model to break out and hack computer systems
- AI almost led the US military to start a war with China, report says
- Google’s Gemini AI hacks 3 companies in security test, then stops
- Exclusive-Anthropic considers releasing new AI model ahead of IPO, sources say
- India forces caller-ID apps to feed spam reports to telcos
- Anthropic selects Accenture as first embedded evaluator to help implement Amodei's slowdown proposal
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Unstructured Data Search, Ask AI, and Advanced Futures Data
- Best AI Stock Research Tools for Professional Investors